NO20080403L - Nanoparticulate megestrol formulations - Google Patents
Nanoparticulate megestrol formulationsInfo
- Publication number
- NO20080403L NO20080403L NO20080403A NO20080403A NO20080403L NO 20080403 L NO20080403 L NO 20080403L NO 20080403 A NO20080403 A NO 20080403A NO 20080403 A NO20080403 A NO 20080403A NO 20080403 L NO20080403 L NO 20080403L
- Authority
- NO
- Norway
- Prior art keywords
- nanoparticulate megestrol
- megestrol formulations
- formulations
- megestrol
- nanoparticulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Abstract
Det beskrives nanopartikkel preparater omfattende megestrol. Megestrol partiklene i preparatet har en midlere effektiv partikkelstørrelse på mindre enn rundt 2000 nm.Nanoparticle preparations comprising megestrol are described. Megestrol particles in the composition have an average effective particle size of less than about 2000 nm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69312705P | 2005-06-22 | 2005-06-22 | |
PCT/US2006/024349 WO2007002315A2 (en) | 2005-06-22 | 2006-06-22 | Nanoparticulate megestrol formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080403L true NO20080403L (en) | 2008-03-19 |
Family
ID=37595838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080403A NO20080403L (en) | 2005-06-22 | 2008-01-21 | Nanoparticulate megestrol formulations |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1901713A2 (en) |
JP (1) | JP2008546796A (en) |
KR (1) | KR20080024213A (en) |
CN (1) | CN101242810A (en) |
AU (1) | AU2006262144A1 (en) |
BR (1) | BRPI0612665A2 (en) |
CA (1) | CA2613466A1 (en) |
EA (1) | EA200800099A1 (en) |
IL (1) | IL188322A0 (en) |
MX (1) | MX2008000396A (en) |
NO (1) | NO20080403L (en) |
WO (1) | WO2007002315A2 (en) |
ZA (1) | ZA200800376B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147605B (en) * | 2015-06-24 | 2019-04-19 | 中国人民解放军军事医学科学院毒物药物研究所 | Progesterone nano-composition and preparation method thereof |
CN105687027A (en) * | 2016-01-26 | 2016-06-22 | 中国科学院生物物理研究所 | Alcohol-free amino acid type rinse-free foam washing solution |
CN105769763A (en) * | 2016-05-25 | 2016-07-20 | 西安德天药业股份有限公司 | Megestrol acetate nanosuspension and preparation method and application thereof |
CN108409821A (en) * | 2018-03-19 | 2018-08-17 | 青岛国海生物制药有限公司 | A kind of preparation method and megestrol acetate of megestrol acetate nanocrystal |
CN108309933A (en) * | 2018-03-19 | 2018-07-24 | 青岛国海生物制药有限公司 | A kind of oral megestrol acetate nanosuspension and preparation method thereof |
CN112891309B (en) * | 2019-11-19 | 2022-07-26 | 北京化工大学 | Megestrol acetate nano dry suspension and preparation method thereof |
CN111643463A (en) * | 2020-07-08 | 2020-09-11 | 西安远大德天药业股份有限公司 | Megestrol acetate dispersible tablet and preparation method thereof |
CN111930838B (en) * | 2020-07-23 | 2023-05-16 | 金陵科技学院 | Time-oriented distributed archive management method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1227626B (en) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION |
US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
ES2380318T3 (en) * | 2002-04-12 | 2012-05-10 | Alkermes Pharma Ireland Limited | Megestrol nanoparticular formulations |
US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
US7879360B2 (en) * | 2003-11-05 | 2011-02-01 | Elan Pharma International, Ltd. | Nanoparticulate compositions having a peptide as a surface stabilizer |
-
2006
- 2006-06-22 CN CNA2006800304246A patent/CN101242810A/en active Pending
- 2006-06-22 CA CA002613466A patent/CA2613466A1/en not_active Abandoned
- 2006-06-22 JP JP2008518396A patent/JP2008546796A/en active Pending
- 2006-06-22 EA EA200800099A patent/EA200800099A1/en unknown
- 2006-06-22 MX MX2008000396A patent/MX2008000396A/en not_active Application Discontinuation
- 2006-06-22 WO PCT/US2006/024349 patent/WO2007002315A2/en active Application Filing
- 2006-06-22 KR KR1020087001652A patent/KR20080024213A/en not_active Application Discontinuation
- 2006-06-22 AU AU2006262144A patent/AU2006262144A1/en not_active Abandoned
- 2006-06-22 EP EP06773791A patent/EP1901713A2/en not_active Withdrawn
- 2006-06-22 BR BRPI0612665-0A patent/BRPI0612665A2/en not_active IP Right Cessation
-
2007
- 2007-12-20 IL IL188322A patent/IL188322A0/en unknown
-
2008
- 2008-01-11 ZA ZA200800376A patent/ZA200800376B/en unknown
- 2008-01-21 NO NO20080403A patent/NO20080403L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0612665A2 (en) | 2010-11-30 |
EA200800099A1 (en) | 2008-06-30 |
IL188322A0 (en) | 2008-04-13 |
JP2008546796A (en) | 2008-12-25 |
EP1901713A2 (en) | 2008-03-26 |
WO2007002315A3 (en) | 2007-04-05 |
ZA200800376B (en) | 2009-03-25 |
AU2006262144A1 (en) | 2007-01-04 |
WO2007002315A2 (en) | 2007-01-04 |
CA2613466A1 (en) | 2007-01-04 |
MX2008000396A (en) | 2009-02-23 |
CN101242810A (en) | 2008-08-13 |
KR20080024213A (en) | 2008-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073559L (en) | Nanoparticulate tacrolimus formulations | |
NO20080403L (en) | Nanoparticulate megestrol formulations | |
ATE419835T1 (en) | NYSTATIN NANOPARTICLE COMPOSITIONS | |
ATE457718T1 (en) | STERILE FILTERED NANOPARTICLE FORMULATIONS OF BUDESONIDE WITH TYLOXAPOL AS SURFACE STABILIZER | |
DE602004021107D1 (en) | MELOXICAN FORMULATIONS IN NANOTEILIC SHAPE | |
UY38044A (en) | SOLID PHARMACEUTICAL COMPOSITIONS INCLUDING PHENOFIBRATE IN NANOPARTICLES | |
DE602004018150D1 (en) | NEW METAXALON COMPOSITIONS | |
ATE387186T1 (en) | NEW COMPOSITIONS OF SILDENAFIL FREE BASE | |
EA200702638A1 (en) | STABLE COMPOSITION (RECIPE) WITH ACETAMINOPHEN NANOPARTICLES | |
ATE343376T1 (en) | NANOPARTICLE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | |
MX336930B (en) | Ganaxolone formulations and methods for the making and use thereof. | |
CY1107810T1 (en) | COMPOSITIONS WHICH HAVE A COMBINATION OF IMMEDIATE LIBERATION AND CONTROLLED LIBERTY CHARACTERISTICS | |
WO2007100466A3 (en) | Nanoparticulate carvedilol formulations | |
NO20073780L (en) | Nanoparticulate candesartan formulations | |
CY1113036T1 (en) | PHARMACEUTICAL FORMS OF MAXESTROL NANOSPHERE | |
WO2010048623A3 (en) | Medical and imaging nanoclusters | |
NZ573555A (en) | Nanoparticulate posaconazole formulations | |
MX2007011495A (en) | Nanoparticulate biphosphonate compositions. | |
ATE459341T1 (en) | NANOPARTICLE SHAPED IMATINIB MESYLATE FORMULATIONS | |
WO2006091780A3 (en) | Nanoparticulate formulations of docetaxel and analogues thereof | |
TW200613479A (en) | Coating formulation having improved rheological properties | |
MX2011007665A (en) | Transparent, colorless infrared radiation absorbing compositions comprising non-stoichiometric tungsten oxide nanoparticles. | |
ATE446018T1 (en) | SWEETENER COMPOSITIONS | |
ATE422155T1 (en) | NANOPARTICLE COMPOSITIONS CONTAINING FENOFIBRATE | |
ATE489941T1 (en) | NON-LAMELLAR PREPARATIONS OF DIOLEOYL-PHOSPHATIDYL ETHANOLAMINE AND POLYSORBATE80 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |